首页|抗菌药普托马尼中3个工艺杂质的(Q)SAR遗传毒性评价与气相色谱-串联质谱法测定

抗菌药普托马尼中3个工艺杂质的(Q)SAR遗传毒性评价与气相色谱-串联质谱法测定

扫码查看
目的 对新型抗结核分枝杆菌药普托马尼各合成路线涉及的3个共性工艺杂质:(S)-叔丁基二甲基硅烷缩水甘油醚(杂质Ⅰ)、(S)-丁酸缩水甘油酯(杂质Ⅱ)、4-三氟甲氧基溴苄(杂质Ⅲ)进行遗传毒性评价并建立相应的质量控制方法.方法 分别采用基于专家规则和统计学原理的2种互补的(定量)构效关系[(Q)SAR]模型(Derek和Sarah)对普托马尼中3个工艺杂质的遗传毒性进行评价和分类;根据评价结果建立气相色谱-串联质谱(GC-MS/MS)法,采用分时段多反应监测(MRM)模式同时对这3个工艺杂质进行测定,并阐述这3个工艺杂质在EI源下的质谱裂解规律.结果 杂质Ⅰ和杂质Ⅲ Derek评估结果均为阳性,Sarah评估结果分别为模棱两可和阴性,依据ICH M7指南分类为3类致突变杂质;杂质Ⅱ Derek评估结果为阳性,Sarah结果显示有明确的Ames阳性实验结果,为2类已知致突变杂质.3个工艺杂质均需按照毒理学关注阈值(TTC)进行控制,建立的GC-MS/MS法经验证3个杂质可有效分离,线性关系良好,方法定量限均低于拟定限度的15%,平均回收率(m=9)分别为105.5%、104.4%和108.5%,重复性RSD(n=6)分别为2.2%、5.8%和2.2%.3批样品均检出杂质Ⅲ.结论 建立的GC-MS/MS法操作简单,专属性强,灵敏度高,可用于普托马尼中3个潜在致突变杂质的测定.由于杂质Ⅱ也是恶唑烷类抗菌药如利奈唑胺、咔哒唑胺、泰地唑胺等的共性工艺杂质,因此本研究也为其他恶唑烷类抗菌药中杂质Ⅱ的质量控制提供了参考.
(Q)SAR genotoxicity evaluation and GC-MS/MS determination of three process impurities in pretomanid,an antibacterial agent
Objective To evaluate the genotoxicity of three process impurities involved in various synthetic routes of pretomanid,a new antimycobacterial drug,and to establish the quantitative method of these three impurities,namely(S)-tert-butyldimethyl(oxiran-2-ylmethoxy)silane(impurity Ⅰ),(S)-oxiran-2-ylmethyl butyrate(impurity Ⅱ),and 1-(bromomethyl)-4-(trifluoro methoxy)benzene(impurity Ⅲ).Methods Two complementary(quantitative)structure-activity relationship[(Q)SAR]evaluation models(Derek and Sarah)based on expert rules and statistics,respectively,were employed to assess and classify the genotoxicity of the three process impurities in pretomanid,and a GC-MS/MS method with the time-segmented multiple reaction monitoring(MRM)mode was subsequently developed for the simultaneous determination of the three impurities.The fragmentation patterns of the three impurities in El source were also discussed in this study.Results The Derek evaluation results were all positive for impurities Ⅰ and Ⅲ,while the Sarah results were equivocal and negative,respectively,indicating impurities Ⅰ and Ⅲ were categorized as class 3 as per ICH M7 guideline.Impurity Ⅱ was regarded as a confirmed mutagenic impurity of class 2 since Sarah showed specific positive results in Ames test.The threshold of toxicological concern(TTC)was applied to control these three impurities.The developed GC-MS/MS method was validated and showed effective resolutions between the impurities with good linearity.The LOQ values of the three impurities were all as low as 15%of the acceptable limit.The average recoveries(n=9)were 105.5%,104.4%,and 108.5%,while the repeatabilities RSD(n=6)were 2.2%,5.8%,and 2.2%,respectively.Impurity Ⅲ was detected in all batches.Conclusion The established method is easy to operate and proved selective and sensitive,which is applicable for quality control of the three potential genotoxic impurities in pretomanid.This study can also be referenced for the quality control of impurity Ⅱ in other oxazolidinone antibacterial drugs like linezolid,cadazolid,and tedizolid,as impurity Ⅱ was the common impurity.

PretomanidGenotoxic impurity(Q)SARGC-MS/MS

钱叶飞、鲁辉、许奇、吴杨、黄逸文

展开 >

苏州市药品检验检测研究中心,苏州市药品不良反应监测中心,苏州 215214

普托马尼 遗传毒性杂质 (定量)构效关系 气相色谱-串联质谱法

2024

中国抗生素杂志
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

中国抗生素杂志

CSTPCD北大核心
影响因子:1.08
ISSN:1001-8689
年,卷(期):2024.49(2)
  • 19